Consort Medical plc (LON:CSRT) insider Jonathan Glenn purchased 13 shares of the company’s stock in a transaction that occurred on Thursday, December 7th. The stock was bought at an average price of GBX 1,176 ($15.83) per share, with a total value of £152.88 ($205.76).

Shares of Consort Medical plc (LON CSRT) opened at GBX 1,148 ($15.45) on Monday. Consort Medical plc has a 12 month low of GBX 960 ($12.92) and a 12 month high of GBX 1,180 ($15.88).

The firm also recently announced a dividend, which will be paid on Friday, February 16th. Shareholders of record on Thursday, January 18th will be paid a dividend of GBX 7.44 ($0.10) per share. The ex-dividend date is Thursday, January 18th. This represents a yield of 0.66%.

A number of analysts recently issued reports on CSRT shares. Stifel Nicolaus restated a “buy” rating and issued a GBX 1,250 ($16.82) price target on shares of Consort Medical in a research note on Thursday, November 9th. Numis Securities lifted their price target on shares of Consort Medical from GBX 1,084 ($14.59) to GBX 1,144 ($15.40) and gave the stock a “hold” rating in a research note on Wednesday, December 6th. Shore Capital restated a “buy” rating on shares of Consort Medical in a research note on Tuesday, December 5th. Finally, N+1 Singer lowered shares of Consort Medical to a “hold” rating in a research note on Tuesday, December 5th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of GBX 1,188.17 ($15.99).

ILLEGAL ACTIVITY WARNING: “Insider Buying: Consort Medical plc (CSRT) Insider Acquires 13 Shares of Stock” was reported by American Banking News and is the property of of American Banking News. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at

About Consort Medical

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.

Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with's FREE daily email newsletter.